Company Filing History:
Years Active: 2002-2011
Title: Nadia Naffakh: Innovator in RNA Technology
Introduction
Nadia Naffakh is a prominent inventor based in Malakoff, France. She has made significant contributions to the field of RNA technology, holding a total of 3 patents. Her work focuses on innovative solutions that have the potential to impact various applications in biotechnology.
Latest Patents
Nadia Naffakh's latest patents include groundbreaking inventions such as the "Chicken RNA polymerase I promoter and the use thereof." This invention relates to a novel polynucleotide that exhibits promoting transcription activity. It includes polynucleotide-containing vectors and their use for the transcription of interesting sequences, such as the production of non-cap RNA viruses. Additionally, she has developed a patent for "Recombinant segmented negative strand virus containing bicistronic vRNA segment with a duplication of its 3′ noncoding flanking sequence, and vaccines and therapeutic compositions containing the same." This invention pertains to recombinant negative strand RNA molecules that can express heterologous proteins in animal cells and construct recombinant viruses capable of expressing heterologous proteins during their multiplication in host animal cells.
Career Highlights
Throughout her career, Nadia Naffakh has worked with notable organizations, including Aventis Pharma and the Institut Pasteur. Her experience in these esteemed institutions has allowed her to refine her expertise in RNA technology and contribute to significant advancements in the field.
Collaborations
Nadia has collaborated with esteemed colleagues such as Sylvie Van Der Werf and Yves Beuzard. These collaborations have further enriched her research and innovation efforts.
Conclusion
Nadia Naffakh is a distinguished inventor whose work in RNA technology has led to valuable patents and collaborations. Her contributions continue to shape the landscape of biotechnology and hold promise for future advancements.